Health & Wellness

Brain Cancer Study Opens at Overlook Medical Center - One of Four Sites in Country

84c7598a938691beaecb_Dr._Kurt_Jaeckle_preferred_2017.jpg
84c7598a938691beaecb_Dr._Kurt_Jaeckle_preferred_2017.jpg

SUMMIT, NJ - Kurt Jaeckle, MD, co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center, and medical director of the Atlantic Center for Research, is leading a phase III study of novel drug VAL-083, which has already shown promise in Glioblastoma and other cancers.  The study is for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the standard of care chemo-radiation therapy. Other study locations are: Kaiser Permanente Los Angeles Medical Center; University of California, San Francisco; and Dent Neurosciences Research Center, Amherst, NY.

“Glioblastoma is very difficult to treat, and I am encouraged by previously reported results with VAL-083,” said Dr. Jaeckle.  “I am also happy that some of the most innovative pharmaceutical companies are looking to Atlantic Health System when they seek to test new types of treatments for brain tumors. The availability of this and other neuro-oncology clinical trials provides a benefit to our patients, and gives me hope for the future.”

Glioblastoma is the most common and most aggressive type of brain cancer, with typical survival of 14-20 months for newly diagnosed patients.  Standard treatment includes surgery to remove as much of the tumor as is safely possible, followed by radiation therapy and chemotherapy with temozolomide.  Nearly all glioblastoma patients will relapse.  Gliosarcoma, which is also being studied in this clinical trial, is a rare and equally aggressive form of glioblastoma. 

Sign Up for E-News

VAL-083 is a first-in-class small molecule chemotherapy drug.  This means that the molecular structure of VAL-083 is not similar in chemical structure (an analogue) or derivative of other small molecule chemotherapeutics approved for the treatment of cancer.  VAL-083 is unique in that it has been shown to overcome cancer cells’ resistance to MGMT, a DNA-repair mechanism that causes recurrent glioblastoma to resist treatment with temozolomide.  Many glioblastoma tumors express large amounts of MGMT, making them difficult to treat with currently available chemotherapies.

According to DelMar Pharmaceuticals, VAL-083 has been assessed in 42 Phase I and Phase II clinical trials sponsored by the National Cancer Institute as a treatment against various cancers. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types, including lung, brain, cervical, ovarian tumors and hematologic (blood) cancers.  Earlier clinical trials have shown that VAL-083 is comparable or superior to other chemotherapies in treating glioblastoma.

To learn more about study inclusion and exclusion criteria, go to the Atlantic Center for Research: research.atlantichealth.org/VAL_083.

About the Gerald J. Glasser Brain Tumor Center

Specialists at the Gerald J. Glasser Brain Tumor Center treat a variety of brain tumors and related conditions, including acoustic neuromas and schwannomas; anaplastic astrocytomas, oligodendrogliomas and low-grade gliomas; brain, epidural and leptomeningeal metastases; ependymomas; glioblastomas; low-grade astrocytomas; lymphomas; meningiomas; medulloblastomas; peripheral nerve, pineal and pituitary tumors; rare glial and neuronal tumors; sarcomas; and spinal cord tumors. The center features a multidisciplinary panel of experts who specialize in neurosurgery, skull base surgery, neuroradiology, radiation oncology, neuro-oncology, medical oncology, neurology, neuropathology and social work. Overlook Medical Center also has the largest CyberKnife® program in the tri-state area for the treatment of brain tumors. The brain tumor center recently moved into its own space on the main level of Overlook Medical Center, in order to foster an optimal, convenient patient-centered experience.

Dr. Jaeckle sees patients at the Gerald J. Glasser Brain Tumor Center of Overlook Medical Center’s Atlantic Neuroscience Institute and Carol G. Simon Cancer Center, 99 Beauvoir Avenue, Summit, NJ. He and other members of the Gerald J. Glasser Brain Tumor Center can be reached at (908) 516-2941. For more information on this clinical trial or other studies, please call the Atlantic Center for Research at (973) 971-5235.

TAP Into Another Town's News:

Sign Up for E-News

Clark

Clark's CityMD Urgent Care Shares Flu Survey

CLARK, NJ - As flu season is in full gear and the probability of catching the flu is a real concern, a majority of Americans admit to taking actions that may contribute to the spread of this highly contagious virus.  According to a recent survey, roughly three out of five Americans who have had the flu or flu-like symptoms (61%) admitted to being out and about the last time they ...

Upcoming Events

Thu, February 22, 6:00 PM

UCEDC, Cranford

Next Level Business Planning

Business & Finance

Carousel_image_248cea245b872fb9c722_resolve_house

Fri, February 23, 12:00 PM

Resolve, Scotch Plains

Free Teen Anxiety Group (Ages 14-17) at Resolve

Carousel_image_cb76d129f430419a337a_sjhsfishfry

Fri, February 23, 5:00 PM

Catanzaro Dining Hall at Saint Joseph High School, Metuchen

Friday Night Lenten Fish Fry

Food & Drink

Clark VFW : Spotlight on Joseph Horling

February’s spotlight is on Joseph Horling , Staff Sergeant US Army 1942-1946.

Joe was born in Rahway NJ on Oct 1, 1920.  He and his brother Anthony were born to Anthony Sr. and Bertha Horling .  Joe’s father was born in Munich and his mother Bertha in Austria. 

Joe enlisted in the Merchant Marines in 1942.  Eight months later, in 1943, he enlisted in the US ...

Giving Back: Learn How to Help Victims of Sexual Violence

February 22, 2018

Every year since 1984, trained volunteers with the Union County Rape Crisis Center have helped victims of sexual violence through the emotional, medical and legal aftermath of trauma. New volunteers are welcome to join the next series of training classes beginning on Thursday, March 22.

No previous experience in crisis counseling is necessary.

“Over the years our Rape Crisis Center ...

First Hand Account: Shouts of Racial Slurs Bring Police to Sparta Theatre

February 22, 2018

SPARTA, NJ – Sparta police were called to the New Vision Sparta Theater on Sunday night because of a woman shouting slurs in a screening of Black Panther.

Former New Jersey Assembly candidate Michael Grace was in the theater when two people started yelling racial slurs including “look at these ‘n-word’” and “can you believe these ...

Don't Rule Out a College Based Solely on Sticker Price Here's Why

Has your child been crossing schools off their college list based solely on the sticker price?  In this week's Tuesday Takeaway, Chris Curran talks about why the sticker price is often far higher than the actual price you will pay.    Take a listen to Chris Curran's latest chat and don't forget to check out his book College Funding ...

Choosing a College With the 'Right' Fit

Do you know if your child is choosing a college with the right fit?  Do you know what the right fit means or why it matters?  Take a listen to Chris Curran's latest chat about why fit matters and don't forget to check out his book College Funding Secrets.  

Check out other columns by Chris here.

Scutari vs Mahr

February 14, 2018

I read with interest in a local newspaper regarding the Union county democrat party political infighting for their “county chair” selection.  There were 2 letters juxtaposed, each one listing supporters of either Senator Scutari or Fanwood Mayor Mahr, who are the two main people vying for the “boss” position.

Although I am a democrat I am not a committee ...

AtlantiCast

AtlantiCast: Episode 12

On this week’s episode of AtlantiCast, decade of excellence makes headlines, as Atlantic Health’s place on Fortune Magazine’s 100 Best Companies to Work For List leads off the newest episode of AtlantiCast. Also on this week’s show, check out the newest “hybrid” operating room at Morristown Medical Center and find out how Atlantic Health is helping local ...

AtlantiCast Medical Minute: Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center

On this episode of the AtlantiCast Medical Minute, we’ll take you inside the Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center, with the center’s director, Jason Lowenstein, MD.

Video Link: https://www.youtube.com/watch?v=1M7euCp86-c